Amethyst Expands Network with Fremman Deal Backed by Pemberton
Deal News | May 07, 2025 | Pemberton Capital
Pemberton Asset Management is backing Fremman Capital’s strategic acquisition of Amethyst Radiotherapy, a leading provider of radiotherapy and cancer care in Europe. Amethyst operates facilities across several European countries including France, Poland, Romania, the UK, Italy, and Austria. The firm is noted for its robust infrastructure comprising about 40 linear accelerators, which are pivotal in pioneering radiotherapy treatments. This investment aims to accelerate Amethyst's expansion plans, enhancing access to quality cancer treatment across Europe.
Sectors
- Healthcare
- Private Equity
Geography
- Europe – Amethyst Radiotherapy operates multiple facilities in European countries including France, Poland, Romania, the UK, Italy, and Austria.
Industry
- Healthcare – Amethyst Radiotherapy operates in the healthcare sector, providing radiotherapy and cancer care services across Europe.
- Private Equity – Fremman Capital's acquisition of Amethyst is a significant private equity investment, supported by Pemberton Asset Management.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Amethyst Radiotherapy | Target company | Company | A leading provider of radiotherapy and cancer care facilities across Europe. |
| Fremman Capital | Bidding Company | Company | Private equity firm acquiring Amethyst Radiotherapy to expand its network and services. |
| Pemberton Asset Management | Investor | Company | Financial firm providing support for Fremman Capital's acquisition of Amethyst Radiotherapy. |